Status:
COMPLETED
Diaphragmatic Thickness and Pulmonary Function in Parkinson's Disease
Lead Sponsor:
Abant Izzet Baysal University
Conditions:
Parkinson's Disease and Parkinsonism
Eligibility:
All Genders
40-80 years
Brief Summary
Ultrasound can give important information about the morphology of the diaphragm and the amount of contraction. Our aim, with the prediction that a restrictive pathology will occur in the pulmonary fun...
Detailed Description
Respiratory complications are one of the most common causes of death in Parkinson's patients. In Parkinson's disease, abnormal flexion of the thoracolumbar spine of 45° or more, which is called campto...
Eligibility Criteria
Inclusion
- Being diagnosed with Parkinson's
- Volunteer to participate in the study
Exclusion
- Being in contact with or suffering from COVID-19
- Having diseases that increase intra-abdominal pressure and venous insufficiency
- Having diseases that affect diaphragmatic motility
- Have had recent thoracic or abdominal surgery
- Having a parenchymal, pleural, or chest wall mass that may cause restriction on a recent chest X-ray or CT
Key Trial Info
Start Date :
December 24 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 15 2023
Estimated Enrollment :
37 Patients enrolled
Trial Details
Trial ID
NCT05194748
Start Date
December 24 2021
End Date
February 15 2023
Last Update
April 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Abant Izzet Baysal University Faculty of Health Science
Bolu, Turkey (Türkiye), 14100